Task: Answer the multiple-choice question.
Query: Which drug exhibits a -4.601\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a) CN(c1ccccc1C(=O)Nc1ccc(F)c(F)c1)S(C)(=O)=O
b) COc1cc2[nH]c3c(=O)n(CCN4CCOCC4)cnc3c2cc1OC
c) CC(C)c1ccc(S(=O)(=O)N2CCC(C(=O)N3CCC3)CC2)cc1
Answer: b. COc1cc2[nH]c3c(=O)n(CCN4CCOCC4)cnc3c2cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cc2[nH]c3c(=O)n(CCN4CCOCC4)cnc3c2cc1OC
COc1cc2[nH]c3c(=O)n(CCN4CCOCC4)cnc3c2cc1OC
7,8-dimethoxy-3-(2-morpholin-4-ylethyl)-5H-pyrimido[5,4-b]indol-4-one